Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership

 
 

WuXi PharmaTech (Cayman) Inc. (WX) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $13.92 Metrics
OS: 563.8 M
Market cap: $7.85 B
Net cash: $270 M $0.48 per share
EV: $7.58 B

 
TTM Valuation
EBITDA
EBIT
EPS

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08
Revenues674.3578.1499.9407.2334.1270.0253.5
            Revenue growth16.6%15.6%22.8%21.9%23.7%6.5% 
Cost of goods sold422.5366.5316.7250.7206.5161.6157.1
Gross profit251.7211.6183.2156.4127.6108.496.3
            Gross margin37.3%36.6%36.7%38.4%38.2%40.1%38.0%
Sales and marketing0.70.715.310.30.17.47.4
Research and development21.211.08.15.40.4  
General and administrative22.715.514.411.510.415.649.4
EBITA104.9106.195.385.974.855.739.6
            EBITA margin15.6%18.4%19.1%21.1%22.4%20.6%15.6%
Amortization of intangibles1.20.92.52.13.33.6 
EBIT103.7105.292.883.871.552.139.6
            EBIT margin15.4%18.2%18.6%20.6%21.4%19.3%15.6%
Pre-tax income112.2114.685.881.090.852.9-19.0
Income taxes-24.5-23.5-0.8-16.60.0-0.4-4.0
            Tax rate    0.0% 21.2%
Earnings from continuing ops112.2114.686.681.090.853.4-15.0
Earnings from discontinued ops     -0.6-49.3
Net income112.2114.686.681.090.852.9-64.2
            Net margin16.6%19.8%17.3%19.9%27.2%19.6%-25.3%
 
Diluted EPS$0.19$0.20$0.15$0.13$0.15$0.09($0.03)
Shares outstanding (diluted)576.6582.0582.4603.5597.5589.2510.2
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy